Renal Cell Carcinoma Metastatic Clinical Trial
Official title:
A Pilot Study of Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell Carcinoma
The trial studies the effects of personalized home-based aerobic and resistance exercises on quality of life, changes in physical activity levels, and the change in inflammatory myokines with the exercise intervention in Interleukin 6 (IL-6), C-reactive Protein (CRP), Leptin, Transforming growth factor beta (TGF-beta), and Interferon (INF) gamma.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05548621 -
A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)
|
||
Recruiting |
NCT04659343 -
TDM for Optimized Outcome in Patients With mRCC.
|
||
Terminated |
NCT06377722 -
Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer
|
Phase 2 | |
Completed |
NCT06161233 -
Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - Italy
|
N/A | |
Not yet recruiting |
NCT06321250 -
A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma
|
Phase 1 | |
Recruiting |
NCT04764487 -
A Web-mediated Follow-up With the Web-application KidneyPRO Versus Standard Follow-up for Patients With Advanced Renal Cell Carcinoma Treated With Axitinib/Pembrolizumab in First Line
|
Phase 3 | |
Active, not recruiting |
NCT03905889 -
A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma
|
Phase 1 | |
Recruiting |
NCT03977571 -
Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial
|
N/A | |
Completed |
NCT03699579 -
Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC
|